A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

PURPOSE: In nonmetastatic hormone receptor-positive and Her2-negative breast cancer, preoperative endocrine therapies can yield outcomes similar with chemotherapy. We evaluated the tolerability and preliminary antitumor activity of preoperative letrozole, everolimus, and carotuximab, a monoclonal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaklavas, Christos, Stringer-Reasor, Erica M., Elkhanany, Ahmed M., Ryan, Kevin J., Li, Yufeng, Theuer, Charles P., Acosta, Edward P., Wei, Shi, Yang, Eddy S., Grizzle, William E., Forero-Torres, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020303/
https://www.ncbi.nlm.nih.gov/pubmed/36735117
http://dx.doi.org/10.1007/s10549-023-06864-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020303/
https://www.ncbi.nlm.nih.gov/pubmed/36735117
http://dx.doi.org/10.1007/s10549-023-06864-9

Ejemplares similares